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Abstract
Background: Gait disorders and gait analysis under single and dual-task conditions are topics of great interest, but
very few studies have looked for the relevance of gait analysis under dual-task conditions in elderly people on the
basis of a clinical approach.
Methods: An observational study including 103 patients (mean age 76.3 ± 7.2, women 56%) suffering from gait
disorders or memory impairment was conducted. Gait analysis under dual-task conditions was carried out for all
patients. Brain MRI was performed in the absence of contra-indications. Three main gait variables were measured:
walking speed, stride frequency, and stride regularity. For each gait variable, the dual task cost was computed and a
quartile analysis was obtained. Nonparametric tests were used for all the comparisons (Wilcoxon, Kruskal-Wallis,
Fisher or Chi2 tests).
Results: Four clinical subgroups were identified: gait instability (45%), recurrent falls (29%), memory impairment (18%),
and cautious gait (8%). The biomechanical severity of these subgroups was ordered according to walking speed and
stride regularity under both conditions, from least to most serious as follows: memory impairment, gait instability,
recurrent falls, cautious gait (p < 0.01 for walking speed, p = 0.05 for stride regularity). According to the established
diagnoses of gait disorders, 5 main pathological subgroups were identified (musculoskeletal diseases (n = 11), vestibular
diseases (n = 6), mild cognitive impairment (n = 24), central nervous system pathologies, (n = 51), and without diagnosis
(n = 8)). The dual task cost for walking speed, stride frequency and stride regularity were different among these subgroups
(p < 0.01). The subgroups mild cognitive impairment and central nervous system pathologies both showed together a
higher dual task cost for each variable compared to the other subgroups combined (p = 0.01). The quartile analysis of
dual task cost for stride frequency and stride regularity allowed the identification of 3 motor phenotypes (p < 0.01),
without any difference for white matter hyperintensities, but with an increased Scheltens score from the first to the third
motor phenotype (p = 0.05).
Conclusions: Gait analysis under dual-task conditions in elderly people suffering from gait disorders or memory
impairment is of great value in assessing the severity of gait disorders, differentiating between peripheral pathologies and
central nervous system pathologies, and identifying motor phenotypes. Correlations between motor phenotypes and
brain imaging require further studies.
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Background
Gait disturbances and cognitive impairment in elderly
people are two major issues that widen the gap between
overall life expectancy and disability-free life expectancy
[1]. Gait abnormalities are one of the main causes of
chronic disability in the elderly population, and their in-
cidence varies greatly with aging, since they occur in ap-
proximately 35% of adults aged over 70 years [2] and in
72% of people aged over 80 years [3]. Gait abnormalities
can lead to mobility limitations, which are associated
with loss of autonomy, reduced quality of life, increased
fall risk, repeated hospitalizations, and premature death
[4]. Moreover, gait performance is also a predictor for
survival [5], cognitive decline [6], fall status [7], and
quality of life [8]. Since the landmark article of Sudarsky
[9], who was one of the first to consider gait disorders in
the elderly as a topic worthy of investigation, few clinical
studies have examined the burden of gait disorders in
the elderly from a clinical approach. Gait disorders are
often referred to as gait instability in the relevant litera-
ture. However, in clinical practice, gait disorders include
a large number of situations, in which gait instability
may be expressed by an unsteady gait without falls,
memory complaints, or obvious gait disorders.
Cognitive decline is another cause of chronic disability
in elderly people and well known to be an independent
risk factor for falls, disability, and dementia. Its preva-
lence increases with age: 25% of adults over 65 years
have cognitive impairments [10]. The co-occurrence of
gait disturbances and cognitive impairment may exist
due to a common underlying pathology [11–13]. More-
over, it has long been known [14] that there is a direct
relationship between cognitive impairment severity and
increased gait abnormalities, in both elderly people [15]
and younger adults [16]. The control of walking depends
on shared brain networks dedicated to cognition (atten-
tion, executive functions, working memory) and motor
control [1, 17].
To assess the interactions between gait and cognition,
the dual task paradigm [1, 7, 18] has become the reference
method. During the dual task test the subject performs an
attention-demanding task, whilst walking at a self-selected
speed. Quantitative Gait assessments are mainly provided
by instrumented walkway [6, 19], or accelerometric re-
cordings [20–22]. Quantitative analysis of gait can be re-
duced to three principal domains which include pace,
rhythm, and variability [6]. However, raw gait variables in-
cluding walking speed, stride frequency, and stride regu-
larity can also be used in this analysis [20, 21].
The decrease in gait variables walking speed, stride fre-
quency, and stride regularity under dual task enables the
calculation of the dual task cost (DTC). These gait modi-
fications are interpreted as the increased cost of involve-
ment of cortical attention processes whilst walking. Such
DTC may reveal subtle brain impairments [23], and may
be related to attention and executive function efficiency
[24]. Therefore, gait assessment under dual-task condi-
tions has been proposed in clinical settings as a window
into brain function in the early stages of cognitive de-
cline [1]. One may conclude that gait analysis under sin-
gle task (ST), provides firstly a measure of the motor
status (or motor function). The DTC measured under
the dual task (DT) method provides a measure of the
cognitive resources [18, 25] dedicated to the control of
gait. Given that a high DTC is linked to cognitive in-
volvement, we hypothesized that DTC measurement
would allow the differentiation between gait disorders of
central nervous system origin from those due to periph-
eral diseases. Lastly, based on the evolution of gait vari-
ables under dual-task conditions, specific motor
phenotypes were described and found to be related to
central nervous system pathologies [26], or to brain MRI
abnormalities [27, 28].
The aim of this observational prospective clinical study
was: 1. To assess the value of gait instability as a clinical
symptom, 2. To quantify gait disorders by means of the
DTC in order to differentiate between peripheral patholo-
gies and central nervous system (CNS) pathologies, 3. To
identify motor phenotypes according to the dual task cost
for stride frequency and gait regularity (authors hypothesize
that stride frequency and stride regularity can evolve inde-
pendently in older patients based on unpublished data), 4.
To search for correlations between these motor phenotypes
and conventional brain MRI findings.
Methods
Trial design
This study is a prospective observational study that in-
vestigates the clinical value of gait instability symptoms
in the elderly patients and quantifies gait disorders
under ST and DT. In order to highlight the clinical im-
pact of gait disorders as well as the contribution of cogni-
tive decline to gait disorders, and to provide a better
understanding of the underlying pathologies, outpatient
consultations dedicated to gait disorders in elderly pa-
tients were launched simultaneously in the rheumatology
unit of a private hospital and the gerontology department
of a public hospital. During these outpatient consultations,
an ambulatory gait analysis was carried out under single
and dual-task conditions, selecting 3 major gait variables:
walking speed, stride frequency and stride regularity. Due
to the broad diversity of pathology that may be involved in
gait disorders, outpatient consultations were linked to a
radiology unit and to a number of specialists, who might
intervene in elderly patients with gait disorders, such as
neurologists, neuropsychologists, otolaryngologists, cardi-
ologists, psychiatrists, etc.; hence the Gait Instability Net-
work (GIN) was formed. Scientific meetings with General
Auvinet et al. Journal of NeuroEngineering and Rehabilitation  (2017) 14:7 Page 2 of 14
Practitioners were held to highlight the strong relationship
between gait and cognition in the elderly and to inform
them of the different services provided by these outpatient
consultations. The study was approved by the Local Eth-
ical Committee of Nantes University, and procedures were
carried out in accordance with the standards listed in the
Declaration of Helsinki, 1964.
Participants
Patients were referred by their general practitioners for
gait disorders, and by the outpatient memory consultation
of the geriatric department to look for gait abnormalities.
Four main reasons for consultation (clinical subgroups)
were identified: The subgroup of Recurrent Falls (RF) in-
cluded patients with a history of 2 or more falls during the
previous year. The Memory Impairment (MI) subgroup in-
cluded patients with predominant memory complaints,
without falls, or obvious gait impairment. The Gait Instabil-
ity (GI) subgroup included patients who expressed a feeling
of unstable gait, without recurrent falls, memory complaint
or obvious gait disorders. The Cautious Gait (CG) sub-
group included patients who moved slowly, with short
strides, with little trunk movement, according to the de-
scription given by Snijders [29]. Enrolled patients should be
able to walk unaided. Exclusion criteria included lack of
French proficiency, less than 4 years of regular education,
institutionalization, any acute medical condition requiring
hospitalization within the past 6 months, and acute depres-
sion, defined by a Hospital Anxiety Depression (HAD)
score of more than 11 out of 21 [30]. All patients were in-
formed about the clinical procedure and provided informed
consent prior to participation in the study.
Outcome measures and baseline tests
The baseline assessment was carried out during the first
consultation by the medical staff, and consisted of the fol-
lowing successive stages: (i) Self-questionnaires given to
patients including the Dizziness Handicap Inventory and
the Hospital Anxiety and Depression scale, (ii) balance
and motor tests: One Leg Balance, Timed Up and Go, and
Timed Chair Rise test (iii) Mini Mental State Examination
(MMSE) for global cognition evaluation, (iv) complete
geriatric examination with the identification of the differ-
ent co-morbidities and medications, and (v) tests used for
quantitative gait assessment as detailed below.
According to the results of the baseline assessment,
patients would require the realization of a brain MRI
examination and if necessary would be referred for a
specialized consultation within the framework of the
GIN. The identification of the main diagnoses and syn-
dromes of gait disorders was carried out by the members
of the GIN during their regular quarterly meetings.
Due to the diversity of diagnoses, homogeneous
pathologies were grouped into 5 main pathological
subgroups (except for fear of falling and Charcot Marie
Tooth disease (peripheral neurological pathology)) as
follows: osteoarthritis and myopathy, vestibular disease,
mild cognitive impairment (MCI), CNS pathologies, and
without diagnosis subgroups.
Quantitative gait assessment
Gait performance under ST and DT task was assessed
using a 3-D-acceleration sensor, a data logger and a com-
puter program for processing the acceleration signal and
calculating the gait parameters (Locometrix® [31, 32]).
From a period of steady state walking of 21 s., the software
calculated the stride frequency (Hz) and the stride regular-
ity (dimensionless), which describes the similarity of
vertical movements over successive strides. Further expla-
nations on the calculation of the variables are described in
previous papers [31, 32]. In addition, walking speed (m/s)
was measured using a stopwatch. For the ST and DT, pa-
tients were asked to walk along a straight 30 m corridor,
free of obstacles, using their regular walking shoes, at their
preferred speed. First the ST trial consisted in walking at
their usual pace. Secondly for the DT trial, patients walked
at their usual pace whilst counting aloud backwards from
50 subtracting serial 1 s (one by one) [19, 20], with no in-
struction to prioritize the gait or cognitive task.
Dual task cost
The Dual Task Cost (DTC) percentage figure was calcu-
lated for each gait variable as [((single task gait value—dual
task gait value)/single task gait value)) x 100 [33–35]. The
three new gait variables DTC (walking speed), DTC (stride
frequency), and DTC (stride regularity) were used to search
for differences between the different clinical subgroups and
between the different main pathological subgroups.
Quartile analysis
In the case of a high degree of dispersion or when
pathological thresholds are not clearly defined, many
works [36] have shown the relevance of categorizing the
variables into quartiles (from minimum to first quartile,
from first quartile to median, from median to third quar-
tile and from third quartile to maximum). We applied
the method of quartiles to the 3 new gait variables DTC
(walking speed), DTC (stride frequency), and DTC (stride
regularity). More specifically, we searched for the different
motor phenotypes on the basis of the assumption that gait
variables stride frequency and stride regularity can evolve
independently in older patients (unpublished data). Con-
sequently, we compared the respective evolution of DTC
(stride frequency) and DTC (stride regularity). Three pos-
sibilities exist for this comparison: both variables will be in
the same quartile, or each variable will be in a different
quartile. Each of these 3 possibilities corresponds to one
motor phenotype.
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N° 1 High value for DTC (stride frequency)—Low
value for DTC (stride regularity) if the quartile of DTC
(stride frequency) is higher than the quartile of DTC
(stride regularity).
N° 2 Same value for DTC (stride frequency) and DTC
(stride regularity) if the quartiles are similar.
N° 3 Low value for DTC (stride frequency)—High
value for DTC (stride regularity) if the quartile of DTC
(stride regularity) is higher than the quartile of DTC
(stride frequency).
Brain Imaging
Conventional brain imaging was carried out according
to the recommendations used in the LADIS study [37]
including the following sequences: T2-weighted images,
including fluid-attenuated inversion recovery (FLAIR).
Semi-quantitative score for white matter hyperintensities
using the age-related white matter changes (ARWMC,
scored 0–30, 0: no white matter hyperintensity; 30: max-
imum degree of white matter hyperintensities), [38], and
Scheltens scored 0–4 (score 0: no atrophy, score 4: se-
vere volume loss of hippocampus), [39] were identified.
Data and statistical analysis
Sample size
When the total sample size across the 3 motor pheno-
type groups is 100, with unequal distribution across the
groups (a minimum of 10 patients for the smallest
group), a Kruskal-Wallis test will have 90% power to de-
tect at a 1% level the difference in means characterized,
by a variance of means of 20 assuming that the common
standard deviation is 10. For the three identified motor
phenotypes issued from quartile analysis, the values for
DTC will be 5, 10, and 20 with a common standard devi-
ation of 10. Consequently, the study will have the power
to detect a difference of 5% across groups of Dual Task
Cost for walking speed: DTC (walking speed), for stride
frequency: DTC (stride frequency) and stride regularity:
DTC (stride regularity).
All values are presented as a percentage for qualitative
criteria and mean ± standard deviation (SD) for quantita-
tive criteria. The differences in baseline gait parameters
between main reasons for consultation (Gait Instability,
Recurrent Falls, Memory Impairment and Cautious Gait)
or other identified subgroups were compared with Chi
square (C) or Fisher’s exact test (F) for qualitative cri-
teria and Wilcoxon’s (W) or Kruskal-Wallis (KW) non-
parametric tests for quantitative criteria (paired test for
gait variable decrease).
As this study is mainly descriptive, no specific correc-
tion was used nor multiple comparisons. A p-value <1%
is considered as highly statistically significant. The
alpha value was set at p <0.05 to indicate statistical
significance, unless otherwise noted. Software SAS® ver-
sion 9.4 was used to perform all statistical analyses.
Results
Main reason for consultation
One hundred and three patients (mean age 76.3 ±
7.2 years); female 58 (56%), were included consecutively in
the study. As expected, males were significantly different
from females in height and Body Mass Index (BMI) (W:
0.01) but no differences were observed in age (W: 0.16),
MMSE (W: 0.26), or number of medications (W: 0.54).
The following four clinical subgroups were identified ac-
cording to the main reason for consultation:
 Gait Instability (GI) (n = 46 (45%)), (F = 22, M = 24),
 Recurrent falls (RF) (n = 30 (29%)), (F = 23, M = 7),
 Memory impairment (MI) (n= 19 (18%)) (F = 7, M=12),
 Cautious gait (CG) (n = 8 (8%)), (F = 6, M = 2).
Demographic and clinical characteristics are presented
in Table 1. No differences in age (KW: 0.23) or number
of medications (KW: 0.14) were found between clinical
subgroups. Significant differences in sex (C: 0.02), height
(KW: 0.01), BMI (W: 0.05), and MMSE (KW: 0.01) were
observed, especially for the group of Cautious Gait that
exhibited the lowest MMSE scores.
Dizziness handicap inventory, timed up and go, one leg
balance test, and timed chair rise test
The Dizziness Handicap Inventory is an auto question-
naire that helps the diagnosis of vestibular origin. Re-
sults of the TUG, according to clinical subgroup were as
follows: MI: 16 ± 3 s, GI: 21 ± 6 s, RF: 23 ± 7 s, CG: 34 ±
15 s, (KW < 0.01). One leg balance and timed chair rise
test were useful measurements to tailor rehabilitation for
balance, and limb strength, respectively.
Main diagnoses, syndromes and main pathological
subgroups
Table 2 shows a wide variety of established diagnoses for
included patients, and the main pathological subgroups.
Neurological disorders were largely predominant (84/103)
followed by musculoskeletal disorders (11/103), mainly
osteoarthritis. Six patients were diagnosed with a vestibu-
lar disorder, 3 with Parkinson’s Disease, and only 1 patient
with a predominant symptom of fear of falling. Finally, 8
patients were undiagnosed. Diagnoses differed signifi-
cantly according to sex (F: 0.03) but not according to clin-
ical subgroups (C: 0.57). According to the established
main diagnoses of gait disorders in included patients, the
following main pathological subgroups were identified:
osteoarthritis and myopathy (n = 11), vestibular diseases
(n = 6), MCI (n = 24), CNS pathologies, (n = 51), and with-
out diagnosis (n = 8).
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Gait variables, under Single and Dual Task, (mean value
and SD) according to main clinical subgroups (Table 3)
Male and female patients showed a significant differ-
ence for walking speed (W: 0.02) during ST but not for
stride frequency (W: 0.40) or stride regularity (W: 0.25).
No significant differences were observed between the
sexes for the 3 gait variables during DT: walking speed
(W: 0.11), stride frequency (W: 0.10), and stride regular-
ity (W: 0.66). All gait variables (walking speed, stride fre-
quency, and stride regularity) under DT had significantly
lower values than under ST conditions (KW < 0.0001).
Walking speed was different between clinical subgroups
under both ST and DT (KW < 0.01for both conditions).
Stride regularity was also different between clinical
subgroups under both ST and DT (KW < 0.01 and 0.05,
respectively). These two variables decreased similarly be-
tween clinical subgroups, which allowed the biomechan-
ical severity of subgroups to be classified from least to
most serious as follows: MI, GI, RF, and CG. SF showed
different median values between subgroups only under
ST (KW 0.04). Furthermore, a paradoxical improvement
in gait variables under DT was observed in some pa-
tients: walking speed in 1 patient, stride frequency in an-
other 1 patient, and stride regularity in 15 patients out
of 103 (mean −8.5 ± −6.2). We considered that the para-
doxical improvement is due to the cueing effect.
Dual Task Cost for each gait variable according to clinical
subgroups (Table 4)
Dual task cost for each gait variable did not differ be-
tween the sexes: DTC (walking speed) (W 0.39), DTC
(stride frequency) (W 0.45), DTC (stride regularity) (W
0.29), or clinical subgroups: DTC (walking speed) (KW
0.90), DTC (stride frequency) (KW 0.70), DTC (stride
regularity) (KW 0.88). The mean values of DTC were
different for each gait variable (multivariate analysis of
variance model p < 0.001): DTC (stride frequency) = 11.1
± 9.7%, DTC (walking speed) = 14.7 ± 12.0%, DTC (stride
regularity) = 21.1 ± 22.0%. A strong correlation (p <
0.001) was observed between the mean values of dual
task cost for each gait variable: R2 DTC (walking speed)/
DTC (stride frequency) = 0.74, R2 DTC (walking speed)/
DTC (stride regularity) = 0.69, R2 DTC (stride fre-
quency)/ DTC (stride regularity) = O.69.
Dual task cost for each gait variable according to main
pathological subgroups (Table 5)
Dual task cost for each of the three gait variables was
different between the main pathological subgroups (KW
< 0.01). The lowest values of DTC were observed in the
subgroup of musculoskeletal diseases whilst the highest
values were observed in the MCI subgroup as well in
CNS pathology subgroups. When the 2 subgroups with
low DTC values (musculoskeletal diseases, vestibular
diseases) were combined on one side and the 2 sub-
groups (MCI, CNS pathologies) with high DTC values
on the other, the comparisons of DTC for walking speed,
stride frequency, and stride regularity showed significant
differences at the 1% threshold.
Quartile analysis and Identification of motor phenotypes
Fig. 1
The quartile analysis illustrates the dispersion of the
values of DTC for each gait variable (Fig. 2 (Box Plot of
DTC for stride regularity)). The box plots of DTC for
walking speed and stride frequency are similar to those
of DTC for stride regularity. Moreover, Additional file 1:
Table S1 shows the mean values of different quartiles for
each variable; DTC (walking speed), DTC (stride fre-
quency), and DTC (stride regularity). For each of these 3
variables, the quartiles are different. However, for each
quartile the values are different between the three
Table 2 Diagnoses differed according to sex (F: 0.03), but not according to clinical subgroups (C: 0.57)
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variables (the three variables have different values). This
method of analysis shows that it is possible to quantify
the DTC value for each of these variables and demon-
strated that the values differ according to the considered
variable. The quartile analysis of DTC for stride fre-
quency and stride regularity allowed the identification of
three different motor phenotypes (KW < 0.01, r =0.69, p
< 0.0001). The first motor phenotype corresponded to
patients in a quartile of DTC for stride frequency higher
than that of DTC for stride regularity (ex q2 and q 1, re-
spectively, n = 30), the second comprised patients in
similar quartiles of DTC for both gait variables (n = 47);
and the third motor phenotype included patients in a
quartile of DTC for stride frequency lower than that of
DTC for stride regularity (ex q1 and q2, respectively, n
= 26). The three motor phenotypes did not show differ-
ences for MMSE or established diagnoses. Patients of
the third phenotype were older (p = 0.02) with an in-
creased number of medications (p = 0.04).
Brain MRI
Only 77 patients out of 103 underwent brain MRI due
to the presence of absolute contra-indications such as
pacemaker or claustrophobia, or patient refusal. Results
showed an Age Related White Matter Changes score
(ARWMC) of 3.5 ± (3.9), range (0-18/30); and a Schel-
tens total score (right and left) of 3.2 ± 1.8 (range 0-8/8).
There was no difference between the male and female
patients (KW: 0.92 and 0.09, respectively). No differ-
ences between the 4 clinical subgroups were noted for
ARWMC and Scheltens scores (KW: 0.42 and 0.59, re-
spectively). No differences were noted between the 3
motor phenotypes for ARWMC, Scheltens scores in-
creased steadily across the three motor phenotypes: first
(2.6 ± 1.6); second (3.3 ± 1.6) third phenotype (4.0 ± 1.9);
(p = 0.05).
Discussion
Gait disorders in the Elderly
Our study included 103 elderly patients referred by their
general practitioners or by the outpatient memory con-
sultation of the geriatric department to look for gait dis-
orders. Patients complaining of gait instability expressed
a feeling of unstable gait, without falls, memory impair-
ment or obvious gait disorder were the main clinical
subgroup. Therefore, clinicians should identify gait in-
stability as a major clinical symptom, and a multi-
disciplinary approach will be necessary to manage this
complaint as it is associated with a large number of
diseases.
Table 5 Dual Task Cost for each gait variable differed between the main pathological subgroups (KW <0.01). The comparison
between the 2 subgroups with low DTC (musculoskeletal diseases, vestibular diseases) combined on one side and the 2 groups
(MCI, CNS pathologies) with high DTC values on the other showed significant differences in DTC for each gait variable (KW: 0.01)
Table 4 In a multivariate analysis of a variance model we observed a strong gait variable effect (p < 0.001) and no clinical subgroup
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Fig. 2 Motor phenotypes identified on the basis of quartile analysis of Dual Task Cost for Stride Frequency and Stride Regularity (KW <0.01, r =
0.69, p < 0.0001). High value of DTC for Stride Frequency—Low value of DTC for Stride Regularity (n = 30). N°2: Same value of
DTC for Stride Frequency and Regularity (n = 47). N°3: Low value of DTC for Stride Frequency—High value of DTC for Stride
Regularity (n = 26)
Fig. 1 The quartile analysis illustrates the great dispersion of the values of the Dual Task Cost for Stride Regularity
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Diagnosis
Abnormal gait resulting from neurological conditions
was largely predominant as shown by other studies [40].
The differences according to sex were mainly due to the
higher prevalence of osteoarthritis in female patients,
which is consistent with the literature [41]. White matter
lesions were found in some of the patients having gait
disorders, in the absence of underlying neurological
pathology [42]. Parkinson’s disease and dizziness were
responsible for gait disorders in only 3 and 6 patients,
respectively, despite the high frequency of these two
conditions in gait disorders. This can be explained by
the fact that patients with Parkinson’s disease are usually
referred to neurologists, and those suffering from dizzi-
ness are referred to ENT specialists. Surprisingly, the
diagnosis of fear of falling, which is a prime concern of
many elderly patients with unstable gait [43] was identi-
fied as the main cause of gait disorders in only one pa-
tient. Nevertheless, fear of falling may be present in a
larger number of patients but may remain hidden by an-
other cause of gait disorders such as MCI. Finally, no
etiology was identified for gait disorders in 8 patients.
The main causes of gait disorders were similar through
the four clinical subgroups (C = 0.85). This finding high-
lights the importance of cognitive and motor interac-
tions in elderly subjects, the relevance of gait analysis
under single and dual-task conditions in the assessment
of gait disorders in elderly people, and the great clinical
value of gait instability as a symptom.
Gait Assessment and gait variables
Gait assessment
Wireless reliable triaxial accelerometers are widely used
for gait analysis in ambulatory conditions [20–22, 44,
45]. From raw acceleration data recorded next to the
body mass center, gait characteristics, such as stride fre-
quency and stride regularity may be calculated. Reliabil-
ity tests such as precision, accuracy [46], effective test-
retest reliability and reproducibility [32, 47, 48] during
stabilized walking were carried out. Accelerometers were
used as they are well adapted to continuous measure-
ment over a period of stabilized walking, which must
consist of at least 20 gait cycles in frail elderly people,
especially if gait variability has to be assessed [49].
Walking speed
Walking speed remains the easiest gait variable to meas-
ure [50]. In clinical settings, walking speed is a meaning-
ful validated marker of functional status and health in
older adults [5]. A walking speed threshold of 1 m/s was
the established threshold of adverse health outcomes in
older adults [51]. In elderly people, a threshold greater
than 1 m/s would be considered normal. In our study,
walking speed under ST was ≥ 1 m/s in both GI and MI
subgroups, which demonstrates that measuring walking
speed is insufficient for the MI and CI clinical sub-
groups, and that other gait variables such as stride fre-
quency and stride regularity have to be measured.
Nevertheless, walking speed remains an interesting vari-
able that reflects the severity of symptoms and their
clinical impact, allowing us to grade the four subgroups
by order of severity as follows: MI, GI, RF, and CG.
Stride Frequency
The rhythmic movement pattern of human gait is estab-
lished at the level of the spinal cord where the so-called
central pattern generators are under the control of the
supraspinal network. [52]. Stride frequency is often inte-
grated as a rhythmic factor, in order to reduce numerous
gait variables to three main factors (pace, rhythm, and
variability factors [6]). Few studies have examined the
clinical importance of a decreased stride frequency, by
itself, in clinical practice. A reduced stride frequency has
been found in patients with subcortical vascular enceph-
alopathy [53]. In the current study, there was no differ-
ence between the four clinical subgroups in terms of
stride frequency mean values under ST or DT. This is in
contrast with the finding of a progressive decrease in
walking speed and stride regularity. This point raises two
questions: the independency of stride frequency with re-
spect to walking speed [54] and stride regularity, and the
clinical significance of a reduced stride frequency.
Gait Regularity or Gait variability
Intra-individual gait variability, which measures the
shortest fluctuation in gait over a period of seconds to
minutes within a single session, has been described as a
consistent clinical marker for high risk elderly patients:
increased risk of falling, developing mobility disability,
or dementia [55]. Gait variability can be measured by
means of spatio-temporal measurements such as step
length, width, step time and stance time, stride time and
swing time. They are markers of impaired control,
arhythmicity and unsteadiness [56]. Gait variability can
also be measured from trunk acceleration, and provides
information related to balance control during walking
[57]. Gait variability measured by autocorrelation func-
tions from trunk accelerations is highly reliable [58].
Gait variability is measured by means of a coefficient of
variation according to the gait variable selected (CV =
SD/menx100). Gait variability increases when there is a
decrement of gait. The variability of gait measured by
the Locometrix® system (autocorrelation functions) is
named regularity. Gait regularity decreases when there is
a decrement of gait. For healthy elderly people aged over
70, there is no difference between the sexes and the
mean value used in clinical practice is 300 ± 30 [32].
Auvinet et al. Journal of NeuroEngineering and Rehabilitation  (2017) 14:7 Page 10 of 14
Compared to standards established within a control
population (300 ± 30), the gait regularity is significantly
decreased for the 4 clinical subgroups under ST condi-
tions including the 2 clinical subgroups MI and GI in
which walking speed is normal (>1 ms). This is in ac-
cordance with the fact that gait variability is the most
prominent gait abnormality with respect to velocity [1],
and is more sensitive in predicting falling when com-
pared to gait speed [59]. Moreover, it is important to
note that patients referred for memory disorders had a
loss of stride regularity under both ST and DT, despite a
walking speed > 1 m/s. This finding raises the question
of adding gait analysis under both ST and DT to mem-
ory consultation for assessing the cognitive resource that
regulates gait [60]. Whatever the considered situation
ST or DT, there is a progressive reduction of the gait re-
gularity between the 4 clinical subgroups in the follow-
ing order: MI, GI, RF and CG. This grading is the same
as that for walking speed.
The paradoxical gait regularity improvement (15/103)
observed under dual-task conditions leads us to suggest
the possibility of the cueing effect. The cueing effect re-
fers to the impact of a rhythmic auditory stimulation to
improve walking parameters. This has already been
proven in many pathological situations such as Stroke
and Parkinson’s disease [61, 62]. In our study, the obser-
vation of improving regularity under the dual task of
spoken countdown raises the question of the mechanism
of the observed cueing effect. This could be of internal
origin by the attention paid to the countdown, or it may
be of external origin by hearing the countdown. Com-
plementary studies are necessary to confirm these results
and to better understand them.
Dual Task Cost and quartile analysis
Walking deterioration resulted in a reduction of the 3
variables (walking speed, stride regularity and stride fre-
quency). The used formula ((single task gait value—dual
task gait value)/single task gait value)) x 100 showed a
positive value, which is consistent with the cost concept
of DTC. There is a lack of consensus concerning the
arithmetic attentional demanding task. Various serial
subtractions have been proposed: S-1[19, 20, 35], S- 3,
or S- 7 [18, 33, 34, 63]. Despite the fact that arithmetic
(attentional) task with a high cognitive demand (S-7) has
been reported with the highest sensitivity [26, 64], we se-
lected the simplest arithmetic one: i.e. S-1, because it
has previously been validated in elderly patients with
cognitive disorders [19, 20, 26, 35]. Another reason is
that in patients with dementia who have a broad range of
pathologies, a simple cognitive task is needed for a reliable
dual-task assessment [64]. Moreover, the walking test used
in the current study consists in walking over a distance of
30 m requiring a sustained attention that is known to be
an additional stress to the dual task [65, 66].
Anxiety and depression which have a negative impact
on cognitive and motor performances [25, 33], had, in
the current study, limited effect on patients’ perfor-
mances under DTC, since the mean score of HAD was
less than 11.
DTC in each gait variable did not vary in the 4 clinical
subgroups (Table 4), whilst the mean DTC showed a
gradual significant increase by going from stride fre-
quency to stride regularity through walking speed. Ac-
cordingly, the identification of a critical threshold for
DTC should consider the variability of DTC values in
the different gait variables. To date, cut-off for DTC
(walking speed), DTC (stride frequency), and DTC
(stride regularity), which allows on the one hand the dif-
ferentiation of healthy populations from pathological
ones, and on the other hand the identification of their
clinical significance is not known [1]. Nevertheless, quar-
tile analysis may represent an approach for this goal.
Furthermore, it is of interest to note that, in daily clin-
ical practice, DTC allows the differentiation between gait
disorders due to peripheral pathologies and those sec-
ondary to central neurological pathologies, whatever the
variable: DTC (walking speed), DTC (stride frequency),
or DTC (stride regularity) (Table 5).
DTC are similarly high for each gait variable between
the main pathological groups (MCI and CNS patholo-
gies) due to impairment of cognitive functions in these 2
subgroups, which results in marked walking decline.
Meanwhile, it is not possible to differentiate DTC ac-
cording to pathologies (MCI, vascular encephalopathy,
Alzheimer’s disease) because of the heterogeneity and
the degree of severity of the corresponding pathologies
[20, 34, 67]. Nevertheless, DTC for the different gait var-
iables are significantly lower for sequelae of stroke (DTC
(walking speed): 9.9 ± 7.8, DTC (stride frequency): 6.2 ±
8.1, DTC (stride regularity) 8.4 ± 17.2, in accordance
with the fact that the prevalence rate of cognitive im-
pairment in patients with a stroke history varies from 24
to 33% [68]. Moreover, a low DTC for osteoarthrosis,
myopathy, and vestibular disease is in line with the ab-
sence of cognitive impairment in gait disorders linked to
these pathologies.
Motor phenotypes and Brain MRI
The identification of motor phenotypes raised logical
questions, especially concerning the clinical value of these
motor phenotypes, and the presence of a link between
these ones and brain imaging findings. Such correlations
have already been shown by some studies [26] in order to
identify motor phenotypes in patients with MCI. On the
other hand, other studies have found a link between in-
creased gait variability and a reduced hippocampal volume
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[28]. In our study, no correlation was found between these
motor phenotypes and clinical subgroups, nor main
pathological subgroups, nor white matter hyperinsensity.
We noted a reduced hippocampal volume from the first
to the third motor phenotype which was characterized by
a quartile stride regularity higher than that of stride fre-
quency, this finding has to be confirmed by other studies.
Therefore, conventional brain MRI is insufficient for the
evaluation of the clinical impact of White Matter hyperin-
tensity since clinical manifestations depend more on
White Matter hyperintensity localizations rather than
their volume [69]. Moreover, according to Allali, links be-
tween motor phenotypes and brain imaging necessitate
different neuroimaging techniques, including structural
and functional magnetic resonance imaging as well as
functional near-infrared spectroscopy [70].
Limitations and future developments
It is preferable to increase the number of patients in
each clinical subgroup to reach at least 30 patients per
subgroup. Cautious gait has to be discussed according to
the characteristics of the so-called High-Level Gait Dis-
order [71]. A more detailed cognitive evaluation using
additional assessment tools other than MMSE alone
should be carried out in order to screen the cognitive
status of patients in the primary outpatient consultation
[72], for instance the Montreal Cognitive Assessment,
which takes into account the evaluation of executive
functions.
Another important issue to address is the best gait var-
iables to use in assessing gait disorders. Walking speed
is an overall measure that is of great importance due to
its simplicity and high clinical relevance. However, it is
the resultant of stride length and stride frequency, which
are controlled by a neurological center other than that
controlling walking speed. Stride length is assumed to be
controlled supraspinally by a basic output from basal gan-
glia to the supplementary motor area [73]. Therefore, fu-
ture studies must take into account both stride frequency
and stride length rather than walking speed alone.
The nature of dual tasking influences the DT decre-
ments [33], as well as the prioritization, which remains a
great difficulty in clinical practice. The factors that con-
tribute to the dual tasking changes in performance such as
education level, physical activity, depression status [74]
could be more detailed. The present findings strengthen
the evidence that gait analysis in older people must be car-
ried out using the dual task paradigm in clinical routines
[21, 60], with an additional point which will be to measure
the concurrent task performance [75, 76].
The strength of this study is the novel clinical ap-
proach and the validated gait test procedures that were
used. To our knowledge, this is the first time that sub-
grouping of patients has been carried out according to
their motor characteristics, using a DT for gait analysis,
and taking into account DTC (stride frequency) and
DTC (stride regularity). It will be necessary for these re-
sults to be replicated, and then their clinical values to be
evaluated by means of case-control follow-up studies.
Moreover, the identification of the links between brain
imaging and motor phenotypes, according to different
grades of the DTC decrement in stride frequency and
stride regularity, necessitates more powerful brain im-
aging than the conventional one. Finally, as a result of
reduced cognitive performance in the different clinical
subgroups in the current study, it is of interest to com-
bine cognitive therapy with motor intervention in clin-
ical practice to enable older patients to move with
greater security and reduce fall risk [72].
Conclusions
In older adults, gait instability without falling is a frequent
complaint, and has to be identified and taken into account
by the clinician. This complaint, as well as recurrent falls,
memory impairment, and cautious gait necessitates a
multi-disciplinary approach. Data taken from scientific lit-
erature revealed that gait analysis under single and dual-
task conditions allows the measurement of the DTC,
which is related to the cognitive resource of the patient.
The measure of DTC for each gait variable can differenti-
ate between peripheral pathologies and CNS pathologies
in the elderly. Furthermore, DTC was found to be specific
for each variable, it increases significantly from stride fre-
quency to stride regularity passing by walking speed. Cut-
off values of dual task cost were identified by quartile ana-
lysis. Three motor phenotypes were identified by means of
DTC for stride frequency and stride regularity. One of
these 3 phenotypes, included patients in a quartile of DTC
for stride frequency lower than that for DTC for stride re-
gularity, was characterized by a higher MRI Scheltens
score. Future prospective case-control studies, with exten-
sive follow up, taking into account DTC for stride fre-
quency and stride regularity should be carried out to
replicate these results and to identify a meaningful cut-off
for clinical applications. Finally, one must look for more
correlations between motor phenotypes and brain MRI
abnormalities.
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